News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,008 Results
Type
Article (58238)
Company Profile (95)
Press Release (635664)
Multimedia
Podcasts (277)
Webinars (26)
Section
Business (210318)
Career Advice (2881)
Deals (33822)
Drug Delivery (235)
Drug Development (78841)
Employer Resources (181)
FDA (16513)
Job Trends (15030)
News (319063)
Policy (31988)
Tag
2025 Best Places to Work (14)
2026 Best Places to Work (18)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Standard (4)
40 Under 40 (4)
Academia (2988)
Academic (1)
Accelerated approval (75)
ADA (53)
Adcomms (43)
Allergies (223)
Alliances (46096)
ALS (285)
Alzheimer's disease (2094)
Antibody-drug conjugate (ADC) (736)
Approvals (17100)
Artificial intelligence (1008)
ASCO (339)
Autoimmune disease (510)
Automation (79)
Bankruptcy (342)
Belgium (44)
Best Places to Work (11649)
BIO (72)
Biologics (115)
BIOSECURE Act (23)
Biosimilars (292)
BioSpace Insights (228)
Biotechnology (66)
Bispecific (60)
Bladder cancer (246)
Brain cancer (98)
Breast cancer (948)
Cancer (7772)
Cardiovascular disease (671)
Career advice (2483)
Career pathing (64)
CAR-T (436)
CDC (80)
CDMO (230)
Celiac Disease (6)
Cell-line development (2)
Cell therapy (1175)
Cervical cancer (67)
Clinical research (70408)
Collaboration (2700)
Commercialization (73)
Company closure (9)
Compensation (1856)
Complete response letters (122)
COVID-19 (3041)
CRISPR (142)
CRO (7)
C-suite (1707)
Cystic fibrosis (177)
Data (10853)
Decentralized trials (4)
Denatured (106)
Depression (222)
Dermatology (203)
Diabetes (807)
Diagnostics (7729)
Digital health (74)
Diversity (14)
Diversity, equity & inclusion (45)
Drug discovery (493)
Drug pricing (239)
Drug shortages (40)
Duchenne muscular dystrophy (376)
Earnings (70833)
Editorial (84)
Employer branding (24)
Employer resources (170)
ESMO (422)
Events (95537)
Executive appointments (1382)
Eye disease (25)
FDA (21425)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (41)
Funding (2248)
Gene editing (304)
Generative AI (94)
Gene therapy (931)
GLP-1 (1356)
Government (5200)
Grass and pollen (6)
Guidances (442)
Healthcare (19377)
Hematology (229)
HIV (126)
Huntington's disease (90)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (153)
Immunology and inflammation (398)
Immuno-oncology (160)
Indications (292)
Infectious disease (3480)
Inflammatory bowel disease (274)
Inflation Reduction Act (17)
Influenza (162)
Intellectual property (382)
Interviews (541)
IPO (16100)
IRA (59)
Job creations (3597)
Job search strategy (2015)
JPM (73)
Kidney cancer (32)
Kidney disease (173)
Labor market (129)
Layoffs (700)
Leadership (70)
Legal (7003)
Licensing (124)
Liver cancer (118)
Longevity (54)
Lung cancer (1087)
Lung diease (26)
Lymphoma (552)
Machine learning (76)
Management (67)
Manufacturing (1562)
Marketing (40)
MASH (253)
Medical affairs (5)
Medical device (13664)
Medtech (13959)
Mergers & acquisitions (19295)
Metabolic disorders (2079)
Middle East (2)
mRNA (334)
Multiple sclerosis (256)
Multispecific (6)
NASH (24)
Netherlands (35)
Neurodegenerative disease (611)
Neuropsychiatric disorders (149)
Neuroscience (4215)
Neurotech (3)
NextGen: Class of 2026 (6778)
Non-profit (4788)
Now hiring (78)
Obesity (989)
Opinion (390)
Ovarian cancer (288)
Pain (342)
Pancreatic cancer (443)
Parkinson's disease (469)
Partnered (47)
Patents (781)
Patient advocacy (8)
Patient recruitment (955)
Patient selection (113)
Peanut (75)
People (64297)
Peptides (42)
Pharmaceutical (27)
Pharmacy benefit managers (40)
Phase 1 (21584)
Phase 2 (30932)
Phase 3 (23683)
Pipeline (14302)
Policy (426)
Postmarket research (2483)
Preclinical (9207)
Press Release (71)
Prostate cancer (393)
Psychedelics (102)
Radioligand (3)
Radiopharmaceuticals (418)
Rare diseases (1554)
Real estate (5701)
Recruiting (79)
Regenerative medicine (35)
Regulatory (27183)
Reports (68)
Research institute (2693)
Resumes & cover letters (449)
Rett syndrome (60)
RNA editing (36)
RSV (102)
Saudi Arabia (1)
Schizophrenia (228)
Series A (385)
Series B (275)
Service/supplier (3)
Sickle cell disease (147)
Special edition (36)
Spinal muscular atrophy (192)
Sponsored (57)
Startups (3600)
State (2)
Stem cells (7)
Stomach cancer (22)
Substance use disorders (22)
Supply chain (162)
Switzerland (24)
Tariffs (100)
Tax incentives (2)
The Weekly (168)
Vaccines (1397)
Venture capital (179)
Weight loss (663)
Wet AMD (7)
Women's health (181)
Women in leadership (2)
Worklife (27)
Date
Today (211)
Last 7 days (860)
Last 30 days (3583)
Last 365 days (30776)
2026 (27806)
2025 (29683)
2024 (34263)
2023 (38819)
2022 (49825)
2021 (54142)
2020 (53407)
2019 (47011)
2018 (35739)
2017 (32664)
2016 (31505)
2015 (36241)
2014 (27498)
2013 (22916)
2012 (24264)
2011 (24943)
2010 (22315)
Location
Africa (944)
Alabama (113)
Alaska (7)
Arizona (394)
Arkansas (16)
Asia (41962)
Australia (7369)
California (15567)
Canada (4487)
China (1971)
Colorado (704)
Connecticut (732)
Delaware (509)
Europe (97284)
Florida (2465)
Georgia (516)
Hawaii (3)
Idaho (64)
Illinois (1302)
India (142)
Indiana (737)
Iowa (34)
Japan (752)
Kansas (150)
Kentucky (56)
Louisiana (62)
Maine (73)
Maryland (1818)
Massachusetts (11020)
Michigan (388)
Minnesota (822)
Mississippi (7)
Missouri (166)
Montana (36)
Nebraska (29)
Nevada (195)
New Hampshire (85)
New Jersey (4208)
New Mexico (37)
New York (4160)
North Carolina (1993)
North Dakota (14)
Northern California (7915)
Ohio (494)
Oklahoma (25)
Oregon (47)
Pennsylvania (2997)
Puerto Rico (38)
Rhode Island (64)
South America (1258)
South Carolina (101)
South Dakota (2)
Southern California (6376)
Tennessee (272)
Texas (2678)
United States (55309)
Utah (498)
Vermont (2)
Virginia (402)
Washington D.C. (78)
Washington State (1245)
West Virginia (4)
Wisconsin (187)
Wyoming (6)
694,008 Results for "heartsciences formerly known as heart test labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
October 6, 2026
·
8 min read
Press Releases
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
September 15, 2026
·
12 min read
Press Releases
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
July 24, 2026
·
8 min read
Press Releases
Zai Lab’s Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer
October 23, 2026
·
10 min read
Press Releases
BioEdge Research Labs Expands Independent Analytical Testing Program
September 6, 2026
·
3 min read
Press Releases
Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
October 8, 2026
·
6 min read
Cardiovascular disease
Tenax shares nosedive as heart failure drug fails in Phase 3
Patients treated with Tenax Therapeutics’ heart failure drug TNX-103 did not show significantly better functional performance—though Leerink analysts found biomarker improvements and subgroup analyses in elderly and more severe patients “very encouraging.”
August 10, 2026
·
2 min read
·
Tristan Manalac
Obesity
Boehringer, Zealand’s obesity drug doesn’t elevate heart risk in key late-stage test
The Phase 3 results help clarify the safety profile of Zealand and Boehringer Ingelheim’s survodutide, but analysts do not think the drug will find utility beyond patients with liver-related risk factors.
November 9, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development
Appointment Follows US$6.5 Million Strategic Financing and Strengthens Board Leadership Alongside David Adelman, Kevin Mayer, Lee Applbaum and James McRoberts
November 13, 2026
·
8 min read
Press Releases
VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
October 21, 2026
·
5 min read
1 of 69,401
Next